| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tomás F Cianciulli, María C Saccheri, Segundo P Fernández, Cinthia C Fernández, Paula A Rozenfeld, Isaac Kisinovsk. Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease. Echocardiography (Mount Kisco, N.Y.). vol 32. issue 5. 2016-01-20. PMID:25684266. |
we describe a 59-year-old-woman suffering from a severe form of fabry disease, mimicking an apical hypertrophic cardiomyopathy with mid-ventricular obstruction. |
2016-01-20 |
2023-08-13 |
Not clear |
| Tomás F Cianciulli, María C Saccheri, Segundo P Fernández, Cinthia C Fernández, Paula A Rozenfeld, Isaac Kisinovsk. Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease. Echocardiography (Mount Kisco, N.Y.). vol 32. issue 5. 2016-01-20. PMID:25684266. |
differentiation of fabry disease from hypertrophic cardiomyopathy is crucial given the therapeutic and prognostic differences. |
2016-01-20 |
2023-08-13 |
Not clear |
| Tomás F Cianciulli, María C Saccheri, Segundo P Fernández, Cinthia C Fernández, Paula A Rozenfeld, Isaac Kisinovsk. Apical left ventricular hypertrophy and mid-ventricular obstruction in fabry disease. Echocardiography (Mount Kisco, N.Y.). vol 32. issue 5. 2016-01-20. PMID:25684266. |
fabry disease should always be suspected in an adult, independently of the pattern of left ventricular hypertrophy. |
2016-01-20 |
2023-08-13 |
Not clear |
| Dominique P Germain, Joel Charrow, Robert J Desnick, Nathalie Guffon, Judy Kempf, Robin H Lachmann, Roberta Lemay, Gabor E Linthorst, Seymour Packman, C Ronald Scott, Stephen Waldek, David G Warnock, Neal J Weinreb, William R Wilco. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. Journal of medical genetics. vol 52. issue 5. 2016-01-06. PMID:25795794. |
fabry disease results from deficient α-galactosidase a activity and globotriaosylceramide accumulation causing renal insufficiency, strokes, hypertrophic cardiomyopathy and early demise. |
2016-01-06 |
2023-08-13 |
Not clear |
| Gianluca Di Bella, Fausto Pizzino, Fabio Minutoli, Concetta Zito, Rocco Donato, Giuseppe Dattilo, Giuseppe Oreto, Sergio Baldari, Giuseppe Vita, Bijoy K Khandheria, Scipione Carer. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. European heart journal. Cardiovascular Imaging. vol 15. issue 12. 2015-09-10. PMID:25190073. |
hypertrophic cardiomyopathy, 'athlete's heart,' fabry disease, and hypertensive cardiomyopathy), and misdiagnosis occurs frequently. |
2015-09-10 |
2023-08-13 |
Not clear |
| B E Smid, L van der Tol, F Cecchi, P M Elliott, D A Hughes, G E Linthorst, J Timmermans, F Weidemann, M L West, M Biegstraaten, R H Lekanne Deprez, S Florquin, P G Postema, B Tomberli, A C van der Wal, M A van den Bergh Weerman, C E Holla. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. International journal of cardiology. vol 177. issue 2. 2015-08-17. PMID:25442977. |
uncertain diagnosis of fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. |
2015-08-17 |
2023-08-13 |
human |
| B E Smid, L van der Tol, F Cecchi, P M Elliott, D A Hughes, G E Linthorst, J Timmermans, F Weidemann, M L West, M Biegstraaten, R H Lekanne Deprez, S Florquin, P G Postema, B Tomberli, A C van der Wal, M A van den Bergh Weerman, C E Holla. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. International journal of cardiology. vol 177. issue 2. 2015-08-17. PMID:25442977. |
screening in subjects with left ventricular hypertrophy (lvh) reveals a high prevalence of fabry disease (fd). |
2015-08-17 |
2023-08-13 |
human |
| Francisca Caetano, Ana Botelho, Paula Mota, Joana Silva, António Leitão Marque. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology. vol 33. issue 3. 2015-07-07. PMID:24661928. |
fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation r118c. |
2015-07-07 |
2023-08-12 |
Not clear |
| Silvia Pica, Daniel M Sado, Viviana Maestrini, Marianna Fontana, Steven K White, Thomas Treibel, Gabriella Captur, Sarah Anderson, Stefan K Piechnik, Matthew D Robson, Robin H Lachmann, Elaine Murphy, Atul Mehta, Derralyn Hughes, Peter Kellman, Perry M Elliott, Anna S Herrey, James C Moo. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. vol 16. 2015-03-30. PMID:25475749. |
cardiovascular magnetic resonance (cmr) derived native myocardial t1 is decreased in patients with fabry disease even before left ventricular hypertrophy (lvh) occurs and may be the first non-invasive measure of myocyte sphingolipid storage. |
2015-03-30 |
2023-08-13 |
Not clear |
| Tomas Palecek, Jitka Honzikova, Helena Poupetova, Hana Vlaskova, Petr Kuchynka, Lubor Golan, Sudheera Magage, Ales Linhar. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS). Journal of inherited metabolic disease. vol 37. issue 3. 2015-02-20. PMID:24173410. |
prevalence of fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective fabry cardiomyopathy screening study (facss). |
2015-02-20 |
2023-08-12 |
Not clear |
| Tomas Palecek, Jitka Honzikova, Helena Poupetova, Hana Vlaskova, Petr Kuchynka, Lubor Golan, Sudheera Magage, Ales Linhar. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS). Journal of inherited metabolic disease. vol 37. issue 3. 2015-02-20. PMID:24173410. |
a number of studies have already investigated the prevalence of fabry disease (fd) in adult patients with unexplained left ventricular hypertrophy (lvh) with rates varying from 0 % up to 12 % reflecting referral and gender bias as well as differences in diagnostic methodology. |
2015-02-20 |
2023-08-12 |
Not clear |
| Christiane Drechsler, Benjamin Schmiedeke, Markus Niemann, Daniel Schmiedeke, Johannes Krämer, Irina Turkin, Katja Blouin, Andrea Emmert, Stefan Pilz, Barbara Obermayer-Pietsch, Frank Weidemann, Frank Breunig, Christoph Wanne. Potential role of vitamin D deficiency on Fabry cardiomyopathy. Journal of inherited metabolic disease. vol 37. issue 2. 2015-01-21. PMID:24141790. |
patients with fabry disease frequently develop left ventricular (lv) hypertrophy and renal fibrosis. |
2015-01-21 |
2023-08-12 |
Not clear |
| Anita C Boyd, Queenie Lo, Kerry Devine, Michel C Tchan, David O Sillence, Norman Sadick, David A B Richards, Liza Thoma. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. vol 26. issue 12. 2014-07-16. PMID:24094560. |
fabry disease is associated with left ventricular hypertrophy (lvh) and myocardial fibrosis. |
2014-07-16 |
2023-08-12 |
Not clear |
| Miriam Shanks, Richard B Thompson, Ian D Paterson, Brendan Putko, Aneal Khan, Alicia Chan, Harald Becher, Gavin Y Oudi. Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. vol 26. issue 12. 2014-07-16. PMID:24125876. |
fabry cardiomyopathy is characterized by progressive left ventricular hypertrophy (lvh) associated with diastolic dysfunction and is the most common cause of death in fabry disease (fd). |
2014-07-16 |
2023-08-12 |
human |
| Dominique P Germain, Frank Weidemann, Ademola Abiose, Manesh R Patel, Marta Cizmarik, J Alexander Cole, Dana Beitner-Johnson, Karelle Benistan, Gustavo Cabrera, Joel Charrow, Ilkka Kantola, Ales Linhart, Kathy Nicholls, Markus Niemann, C Ronald Scott, Katherine Sims, Stephen Waldek, David G Warnock, Jörg Strotman. Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry. Genetics in medicine : official journal of the American College of Medical Genetics. vol 15. issue 12. 2014-07-14. PMID:23703683. |
the aim of this study was to evaluate the progression of left ventricular hypertrophy in untreated men with fabry disease and to assess the effects of agalsidase-β (recombinant human α-galactosidase a) on left ventricular hypertrophy. |
2014-07-14 |
2023-08-12 |
human |
| Jeffrey B Geske, Hayan Jouni, Marie C Aubry, Bernard J Gers. Fabry disease with resting outflow obstruction masquerading as hypertrophic cardiomyopathy. Journal of the American College of Cardiology. vol 63. issue 17. 2014-06-24. PMID:24632283. |
fabry disease with resting outflow obstruction masquerading as hypertrophic cardiomyopathy. |
2014-06-24 |
2023-08-12 |
Not clear |
| María C Saccheri, Tomás F Cianciulli, Jorge A Lax, Juan A Gagliardi, Guillermo L Cáceres, Alejandra E Quarin, Isaac Kisinovsky, Paula A Rozenfeld, Ricardo C Reisi. Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography (Mount Kisco, N.Y.). vol 30. issue 9. 2014-06-04. PMID:23600802. |
fabry disease (fd) is characterized by left ventricular hypertrophy (lvh). |
2014-06-04 |
2023-08-12 |
human |
| Wim Terryn, Gert Deschoenmakere, Jan De Keyser, Wouter Meersseman, Wim Van Biesen, Brigitte Wuyts, Dimitri Hemelsoet, Hilbert Pascale, Julie De Backer, An De Paepe, Bruce Poppe, Raymond Vanholde. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. International journal of cardiology. vol 167. issue 6. 2014-04-22. PMID:22805550. |
prevalence of fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. |
2014-04-22 |
2023-08-12 |
Not clear |
| Wim Terryn, Gert Deschoenmakere, Jan De Keyser, Wouter Meersseman, Wim Van Biesen, Brigitte Wuyts, Dimitri Hemelsoet, Hilbert Pascale, Julie De Backer, An De Paepe, Bruce Poppe, Raymond Vanholde. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. International journal of cardiology. vol 167. issue 6. 2014-04-22. PMID:22805550. |
patients with fabry disease (fd) develop progressive left ventricular hypertrophy (lvh). |
2014-04-22 |
2023-08-12 |
Not clear |
| Kazutoshi Mawatari, Hideo Yasukawa, Toyoharu Oba, Takanobu Nagata, Tadayasu Togawa, Takahiro Tsukimura, Sachiko Kyogoku, Hideki Ohshima, Tomoko Minami, Yusuke Sugi, Hitoshi Sakuraba, Tsutomu Imaizum. Screening for Fabry disease in patients with left ventricular hypertrophy. International journal of cardiology. vol 167. issue 3. 2014-04-02. PMID:23168011. |
screening for fabry disease in patients with left ventricular hypertrophy. |
2014-04-02 |
2023-08-12 |
Not clear |